What question did this study set out to answer?

This review aims to summarize and discuss emerging treatment strategies for natural killer/T-cell lymphoma (NKTCL).

Novel target and treatment agents for natural killer/T-cell lymphoma

View Full Paper

Ask AI

Bookmark

Authors

Review summarizes novel treatments improving survival in relapsed natural killer/T-cell lymphoma patients, indicating future potential.

This review aims to summarize and discuss emerging treatment strategies for natural killer/T-cell lymphoma (NKTCL).
Utilized high-throughput screening to understand the molecular basis of NKTCL.
Examined asparaginase-containing regimens and novel agents in initial clinical studies for relapsed and refractory NKTCL.
Asparaginase-containing regimens substantially improved survival outcomes in NKTCL patients.
Novel treatments being developed include immune checkpoint inhibitors and chimeric antigen receptor T cells.
Initial clinical studies show promise for expanding treatment options in NKTCL.

Tian et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark